CPT code 22903 represents the surgical excision of an abnormal soft-tissue mass located immediately below the skin of the abdominal wall with the specimen submitted for laboratory analysis and measuring 3 cm or greater. This code is used to capture operative services for removal and diagnostic evaluation of sizable subcutaneous masses, which has implications for surgical coding, pathology billing, and national utilization monitoring. Accurate coding supports appropriate payment, clinical documentation, and tracking of surgical oncology and general surgery workload.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how 22903 is defined clinically, typical sites of service, and the service type represented. The publication provides benchmarking context, common modifier usage (listed separately), and implications for claim submission and documentation. Policy updates, reimbursement trends, and payer-specific prior authorization or coverage nuances are addressed where available.

This national-level summary is intended for coders, billing teams, clinicians, and policy analysts seeking a clear statement of the code's clinical intent, operational settings, and the types of analyses and benchmarks included in the full publication. Data not available in the input is noted where applicable.